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Abstract
Taurine and glutamine are the most abundant intracellular free amino acids in mammalian hearts where changes in their
intracellular concentrations are likely to influence a number of cellular activities. In this study we investigated the effects of
ischaemia and reperfusion on the intracellular concentrations of taurine and glutamine in the hearts of patients undergoing
 .coronary artery bypass surgery using cold crystalloid or cold blood cardioplegic solutions. Ischaemic arrest 30 min , using
 .  .cold crystalloid cardioplegic solution ns19 , decreased the intracellular concentrations mmolrg wet weight of taurine
 .  .from 9.8"0.8 to 7.7"0.7, P-0.05 and glutamine 8.7"0.5 to 7.2"0.6 . After 20 min of normothermic reperfusion
 .the fall in taurine and glutamine was maintained 7.5"0.5 and 7.4"0.7 for taurine and glutamine respectively .
 .Myocardial ischaemic arrest with cold blood cardioplegic solution ns16 did not cause a significant fall in tissue taurine
or glutamine. However, on reperfusion there was a marked fall in the intracellular concentrations of taurine 9.4"0.5 to
.  .6.5"0.7 and glutamine 8.0"0.7 to 5.8"0.4 . The fall in amino acids was associated with a fall in ATP and a rise in
tissue lactate. This work demonstrates that irrespective of the cardioplegic solution used to arrest the heart, there is a marked
fall in tissue taurine and glutamine which may influence the extent of recovery following surgery. The fall in taurine is
largely due to efflux whereas changes in glutamine are due to both transport and metabolism. Ischaemia, hypothermia and
changes in the transmembrane concentration gradients are the likely factors responsible for the changes in tissue amino
acids.
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1. Introduction
The slowly metabolised non-protein b-amino acid
taurine is present at high concentration in mammalian
 .heart cells ranging between 3–40 mM but at a
much lower concentration in the plasma less than 0.1
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.mM , thus creating a large concentration gradient
w xacross the sarcolemma 1,2 . This gradient is main-
tained by a Naq-taurine symport using the Naq elec-
w xtrochemical gradient 1–3 . The concentration of tau-
rine is raised in the blood of patients following acute
w x w xmyocardial infarction 4 , unstable angina 5 and
w xcardiac surgery 6,7 . Work on animal experimental
models has provided direct evidence for a fall in
taurine in heart cells during cardiac insults e.g.,
w x.Refs. 3,8–10 . A fall in tissue taurine will influence
myocardial function as taurine affects cellular cal-
cium homeostasis and taurine deficiency is associated
w xwith development of cardiomyopathy 11,12 .
In contrast to taurine and until recently little was
known about the role of intracellular glutamine and
w xits transport in heart cells 13,14 . Glutamine is one
of the principal free intracellular amino acids in
mammalian heart cells, and it is important as a
nitrogen donor for the biosynthesis of a number of
compounds such as nucleotides and amino acids see
w x.Ref. 14 . Furthermore, muscular glutamine has been
shown to increase protein synthesis and decrease
protein degradation and regulate glycogen metabolism
w x13–15 . Work on isolated Langendorff guinea-pig
hearts has shown that intracellular glutamine levels
are influenced by different experimental conditions
and that its transport, which is Naq-dependent and is
faster than other amino acids, is largely responsible
w xfor these changes 8,14,16,17 .
A fall in the intracellular concentration of both
taurine and glutamine is seen in the hearts of patients
undergoing coronary artery surgery during ischaemia
w xusing cold crystalloid cardioplegic solution 18 . This
fall was attributed to a rise in intracellular Naq
w qx .concentration Na , induced by ischaemia andi
hypothermia, and the absence of the amino acids
from the extracellular perfusate. Because taurine and
glutamine have several important cellular functions, a
fall in their intracellular concentration may influence
the functional recovery of the heart following surgery.
It is likely, however, that on reperfusion, these stores
will be replenished. Alternatively, the use of cold
 .blood cardioplegic solution contains amino acids to
arrest the heart may prevent the fall in amino acids.
We have therefore set out to study the changes in
myocardial intracellular amino acids during is-
chaemia and on reperfusion, comparing two methods
of myocardial preservation: antegrade cold crystalloid
or blood cardioplegia. Preliminary data have been
w xpublished elsewhere 19,20 .
2. Materials and methods
 .Patients ns35 undergoing elective coronary
artery bypass surgery were randomised to one of two
accepted techniques of myocardial protection: ante-
 .grade cold 48C crystalloid St Thomas’ I cardio-
plegic solution contents in mmolrl: 16 MgCl P2
6H O, 2 CaCl , 20 KCl, 147 NaCl, 1.0 procaine2 2
.  .HCl or cold 48C blood cardioplegic solution con-
taining blood and St Thomas’ I cardioplegic solution
 .4 blood: 1 crystalloid and adjusted to give a final
Kq concentration of 20 mM. Cardioplegic solution
was administered as a 1-litre bolus at the start of the
ischaemic period. Infusions were repeated at 30-min
intervals or earlier if electrical activity returned. The
study was approved by the hospital ethics committee
and patients informed consent obtained.
Preoperative and intraoperative variables for the
 .two groups were comparable Table 1 .
2.1. Collection of biopsies
Three myocardial biopsy specimens 4–14 mg wet
.weight were taken from the apex of the left ventricle
Table 1
Patients’ characteristics: preoperative and intraoperative variables
of patients undergoing coronary artery bypass surgery using
crystalloid and blood cardioplegia
Crystalloid Blood
cardioplegia cardioplegia
 .Age years 62.4 " 8.3 58.6 " 5.9
 .Sex MrF 17r2 15r1
Diabetes 2 1
Hypertension 54
Previous MI 8 10
 .Ejection fraction % 64.4 " 9.4 62.3 " 9.4
Unstable angina class I 3 2
Unstable angina class II 3 3
Unstable angina class III 0 1
No. of grafts 2.92" 0.7 3.07" 0.8
 .CPB time min 94.4 "22.2 85.1 "17.2
 .Ischaemic time min 44.6 "12.2 41.0 "13.7
Inotrope requirements 3 2
Perioperative MI 1 1
Death 0 0
Values are mean"S.D. CPB, cardiopulmonary bypass; MI, myo-
cardial infarction.
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using a ‘Trucut’ needle. The first biopsy was taken
 .immediately approx. 5 min after institution of car-
diopulmonary bypass. The second biopsy was taken
after 30 min of ischaemia 30 min after aortic cross-
.clamping and the third approximately 20 min after
reperfusion and following the removal of cross clamp.
In this study there was no difference in myocardial
temperature during the collection of the second biopsy
19.9"1 for crystalloid vs. 19.7"18C for blood
.cardioplegia group . In cases where the cross-clamp-
ing period exceeded 45 min, an extra biopsy speci-
men was also taken. Each specimen was immediately
frozen in liquid nitrogen until processing for the
analysis of amino acids and other metabolites.
2.2. Determination of amino acids, ATP and lactate
in biopsy specimen
In the first half of this study, 16 patients were
recruited for amino acid analysis only. The procedure
followed to extract free amino acids was similar to
w xthat described previously 18,21 . In brief, tissues
were thawed, weighed and homogenised in ice-cold
HPLC water. A sample of the homogenate was taken
for protein determination and the rest transferred to
an Eppendorf tube using 400 ml HPLC water and
centrifuged at 400=g for 10 min. The filtrate was
deproteinised using Millipore 10K molecular weight
cut-off limit ultrafiltration units for 15 min at 8500=
g.
In the second half of this study, a further 19
patients were initially recruited for ATP measure-
ments only. However, after a series of control experi-
ments we were able to use the same extract for amino
acids determinations. Free amino acids levels deter-
mined in the ATP extract using this procedure were
similar to those measured using the one described
above. Subsequently, all amino acid data were pooled
together for analysis. ATP extraction was carried out
w xas described previously 21 . In brief, frozen biopsy
specimens were crushed under liquid nitrogen and the
resultant powder was extracted with perchloric acid.
The extracts were centrifuged at 1500=g for 10 min
at 48C. The supernatant was neutralised and used for
amino acid and ATP determinations. ATP content
was measured using a bioluminescent assay described
w xelsewhere 22 . In addition to amino acids and ATP
measurements, we were also able to measure lactate
content in some of the extracts. Lactate was measured
using a plasma lactate determination kit from Sigma
 .Diagnostics Sigma, Poole, UK . It must be noted,
however, that lactate concentrations reported here
may not be a true reflection of the actual amounts
found in the tissues. This is because the kit is nor-
mally used to measure a much more concentrated
samples. In addition we were only able to measure
lactate in five patients from the crystalloid group.
Amino acids were determined according to the
w xWaters Pico-Tag method 23 and similar to that
w xreported earlier 21 . Essentially, 100 ml of the ultra-
 .filtrate or extract was dried using vacuum, centrifu-
gation and cold trap on a Savant SV160 Farming-
.dale, NY, USA . Free amino acids were derivatised
using phenylisothiocyanate. The phenylisothiocar-
bamyl derivatised amino acids were separated by
HPLC using a 30-cm Pico-Tag column Millipore
.Corp., Milford, MA, USA with two Waters delivery
 .pumps A and B at a constant flow of 1 mlrmin
with the following gradient: 100% A for 13.5min,
97% A for 10.5 min, 94% A for 6 min, 91% A for 20
min, 66% A for 12.5 min and 0% A for 4 min. The
solvents used were for A: 132 mM Na acetate, 470
 .mlrl triethylamine pH 6.4 and 6% acetonitrile.
Solvent B was 60% acetonitrile. Derivatised amino
 .acids were detected at 254 nm 468C using a Waters
486 detector. Quantitative and qualitative analysis
 .was carried out using amino acid standards Sigma
and the acquired data was processed using the soft-
ware Millenium 2000 supplied by Waters, Millipore
 .UK , Watford, Herts. Chemicals needed to derivatise
amino acids and separate them were also obtained
from Waters Millipore.
Amino acids concentrations were expressed per
wet weight. In addition and in several biopsies, the
concentrations were expressed per protein concentra-
 .tion data not shown and showed a similar trend to
that expressed per wet weight. Protein determination
w xwas carried out according to the Lowry method 24
using a protein determination kit from Sigma. Bovine
 .plasma albumin Sigma was used as a standard.
2.3. Amino acid determination in plasma
Blood from patients undergoing open heart surgery
was collected and processed before the operation.
Blood plasma was deproteinised using Millipore 10K
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molecular mass cut-off limit ultrafiltration units for
15 min at 8500=g. The procedure for amino acid
determination was the same as described above.
2.4. Troponins T and I determination
Recent years have witnessed an increased use of
myocardial troponins T and I as markers of myocar-
w xdial injury 25,26 . These proteins are more sensitive
and specific test for myocardial cell damage. Deter-
mination of blood concentration of troponins T and I
was conducted prior to surgery and at 4, 12, 24 and
48 h postoperatively. The analysis was carried out
using diagnostic kits provided by Boehringer
 .Mannheim UK Lewes, East Sussex and Sanofi Di-
 .agnostics Pasteur Guilford, Surrey, UK .
2.5. Data collection and analysis
Intergroup differences were analysed by ANOVA
 .Fisher’s PLSD using a Statview package provided
on a Macintosh PC. Correlation matrix was calcu-
lated and the significance determined using Fisher’s r
to z. Level of statistical significance was taken at
95%.
3. Results
3.1. Plasma and muscle amino acids concentration
Table 2 shows the resting myocardial concentra-
tion for the amino acids taurine and glutamine in the
Table 2
Concentration of amino acids in heart cells and in the plasma of
patients undergoing coronary artery surgery using cold crystalloid
 .  .ns19 and cold blood ns16 cardioplegia
Group Taurine Glutamine
Crystalloid Muscle 9.76 " 0.79 8.67 "0.50
Plasma 0.043" 0.005 0.422"0.016
Muscler 290 "50 21 "1.5
plasma
Blood Muscle 9.36 " 0.53 8.04 "0.64
Plasma 0.037" 0.006 0.444"0.017
Muscler 311 "40 19 "1.7
plasma
 .The concentration of amino acids mmolrg wet weight in
ventricular biopsies collected immediately after institution of
cardiopulmonary bypass is taken as resting level. Also shown is
 .the concentration in the plasma mmolrml and the amino acids
gradient across the sarcolemma expressed as musclerplasma
ratio for each group.
Fig. 1. The intracellular concentration of the amino acids taurine
 .  .A and glutamine B in ventricular biopsies taken from patients
during coronary artery bypass surgery using cold crystalloid
 .  .ns19 or blood ns16 cardioplegia. Biopsy 1 was collected
immediately after institution of cardiopulmonary bypass, biopsy 2
collected after 30 min of ischaemia and biopsy 3 collected 20
min after reperfusion. Values are mean"S.E. ) Significantly
different from biopsy 1. )) Significantly different from biopsies
1 and 2.
two groups of patients. The intracellular concentra-
tion of amino acids in the first biopsy, collected
immediately after institution of cardiopulmonary by-
pass, was taken as the free resting level. Although the
intracellular concentration of taurine was slightly
higher than glutamine, the plasma levels of glutamine
 .were more than 10 fold higher than taurine Table 2 .
Therefore the concentration gradient expressed as the
muscle-to-plasma ratio shows taurine having a ratio
of approximately 300 compared to 20 for glutamine
 .Table 2 .
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 .  .Fig. 2. The intracellular concentration of the amino acids taurine A and glutamine B in four ventricular biopsies taken from patients
 .  .during coronary artery bypass surgery using cold crystalloid ns6 or blood ns5 cardioplegia when the ischaemic time exceeded 45
min. Biopsy 1 was collected immediately after institution of cardiopulmonary bypass, biopsies 2 and 2a collected after approximately 30
and 45 min of ischaemia, and biopsy 3 collected 20 min after reperfusion. Values are mean"S.E. )) Significantly different from
biopsies 1 and 2.
 .Fig. 3. Time-dependent release of troponin T and troponin I measured in the blood of patients before 0 time and following coronary
artery surgery using crystalloid or blood cardioplegia. Values are mean"S.E. The release of troponins was similar for both crystalloid
and blood cardioplegia groups.
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3.2. Changes in taurine and glutamine during is-
chaemia and reperfusion
After 30 min ischaemia using cold crystalloid car-
dioplegic solution, there was a significant 21% fall in
the intracellular concentration of taurine and 28% fall
 .in glutamine Fig. 1 . After 20 min of normothermic
reperfusion with blood, there was no further signifi-
 .cant change in taurine or glutamine Fig. 1 .
In hearts arrested with cold blood cardioplegic
solution, there was an insignificant 10% fall in tau-
rine and no change in the intracellular concentration
 .of glutamine Fig. 1 . However, on reperfusion there
 .was a 40% fall in taurine compared to biopsy 1 and
a 54% fall in glutamine. On reperfusion, the final
levels for taurine and glutamine in the crystalloid
group were similar to those in the blood group Fig.
.1 .
In several patients six in the crystalloid group and
.five in the blood group , the ischaemic period was
extended beyond 45 min and a second biopsy was
collected at 45 min and analysed for amino acids. In
these biopsy specimens, the changes in amino acids
were not significantly different from 30-min biopsies
 .Fig. 2 .
3.3. Changes in markers of myocardial injury
Table 3 shows that after 30 min of hypothermic
ischaemia using crystalloid cardioplegic solution,
there was a significant fall in ATP concentration.
This fall was sustained after 20 min of normothermic
reperfusion. In contrast to crystalloid cardioplegic
solution, ischaemic arrest with blood cardioplegic
solution resulted in a small insignificant fall in ATP.
On reperfusion, however, there was a marked fall
which was statistically significant when compared to
the ATP levels in the preischaemic biopsies. The
changes in tissue ATP were associated with changes
 .in the opposite direction for lactate Table 3 . How-
ever, statistical significance was reached only in the
blood cardioplegia group but not in the crystalloid
cardioplegia group. It must be noted that we were
only able to use extracts from five patients in the
crystalloid cardioplegia group for lactate determina-
tion.
In this study we measured the release of myocar-
dial troponins T and I as markers of reperfusion
Table 3
ATP and lactate concentrations measured in perchloric acid
extracts of pulverised frozen ventricular biopsies taken from
hearts arrested using cold crystalloid or cold blood cardioplegia
Metabolite Biopsy no. Crystalloid Blood
 .ATP 1 control 3.0"0.4 2.9"0.5
) .2 ischaemia 1.9"0.3 2.5"0.4
) .3 reperfusion 2.0"0.2 1.5"0.3
 .Lactate 1 control 21 "4.0 20 "2.5
 .2 ischaemia 32 "7.8 33 "6.5
) .3 reperfusion 31 "7.6 39 "8.7
Biopsy 1 was collected immediately after institution of cardiopul-
monary bypass, biopsy 2 collected after 30 min of ischaemia and
biopsy 3 collected 20 min after reperfusion. Values are mean"
 .S.E. In the blood group, the same patients ns10 that were
recruited for ATP measurements were also used for lactate
determination. On the other hand, of the nine patients that were
recruited for ATP measurements in the crystalloid group, only
five were used for lactate determination. Lactate values may not
 .necessarily reflect the exact tissue levels see text .
) Significantly different from biopsy 1.
damage. Fig. 3 shows a time-dependent release of
troponin T and troponin I before and at different
periods after surgery. There was no significant differ-
ence in the release of troponins using cold crystalloid
or cold blood cardioplegia.
4. Discussion
In this work we present data showing the changes
in the intracellular concentrations of the most abun-
dant amino acids, taurine and glutamine, in the ven-
tricles of patients undergoing coronary artery surgery.
The changes were monitored after ischaemic arrest
using cold crystalloid or blood cardioplegic solutions,
and after 20 min of normothermic reperfusion. The
changes in these amino acids and in ATP are not
likely to be due to changes in the intracellular vol-
ume, as there were changes in the opposite direction
for lactate, and when the concentrations of amino
acids were expressed per protein content, similar
trends were also seen.
4.1. Ischaemic arrest with cold cardioplegic solutions
Myocardial arrest using crystalloid cardioplegic
solution but not blood cardioplegic solution, renders
the heart ischaemic as evidenced by a fall in ATP and
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an apparent increase in tissue lactate content Table
.3 . Work on experimental models has shown that
myocardial ischaemia results in a fall in adenine
nucleotides accompanied with cellular acidosis. These
changes will reduce the Na-pump activity and will
activate the NaqrHq exchanger to influx Naq, re-
w qx w xsulting in an accumulation of Na 27–30 . Asi
hypothermia inhibits the Na-pump, a further rise in
w qxNa is expected during hypothermic ischaemiai
w x29 .
Ischaemic arrest with crystalloid cardioplegic solu-
tion was associated with a fall in the intracellular
 .concentrations of taurine and glutamine Fig. 1 . The
fall in taurine is due to transport because taurine is a
non-protein amino acid and is very slowly metabolised
w x q27,31 . The transport of taurine is Na -dependent as
shown by work on sarcolemmal vesicles, isolated
w xheart cells and hearts 1,2 . The high sarcolemmal
distribution ratio for taurine during control pre-
.ischaemic conditions suggests an uptake requiring
energy. The metabolic energy needed to influx tau-
y1 rine is 14.7 kJ mol calculated using the equation
w x w x y1 y1RT ln AA r AA where Rs8.314 J K mol isi o
the gas constant, Ts3108C is the absolute tempera-
w x w xture and AA and AA are intracellular and extra-i o
.cellular concentrations respectively . The available
Naq electrochemical energy at approximately 14.5 kJ
y1 w xmol 3 is just enough for maintaining taurine
gradient, assuming a stoichiometry of 1:1.The set-
tings of the transporter can be reversed, to efflux
taurine, by the absence of the extracellular amino
w qxacid, membrane depolarisation and a rise in Na .i
These conditions are likely to occur during arrest
with cold crystalloid cardioplegic solution. This car-
dioplegia does not contain amino acids and the com-
bined hypothermia and ischaemia will depolarise the
w qxmembrane and induce a rise in Na .i
Unlike taurine, changes in the intracellular concen-
tration of glutamine is likely to be the net result of
protein breakdown and synthesis and metabolism as
well as transport. Measurements of branched-chain
amino acids do not support significant changes in
protein synthesis or breakdown during the duration of
ischaemia and reperfusion Suleiman et al., unpub-
.lished data . Work on rat hearts has provided evi-
dence for the absence of glutamine synthetase thus
.inability of heart cells to synthesise glutamine and
the presence of glutaminase Rennie et al., personal
.communication . Ischaemic heart cells are known to
w xutilise glutamate for energy production 32 and a fall
in tissue glutamate does occur in the hearts of pa-
tients undergoing coronary artery bypass surgery
w x .18 ; Suleiman et al., unpublished observations . It is
possible therefore that the conversion of glutamine to
glutamate provides the much-needed substrate for the
Krebs cycle for energy production during ischaemia.
In addition to metabolism, the transport of glutamine,
q w xwhich is both very fast and Na -dependent 14 , may
also contribute to the observed fall in the amino acid.
The transmembrane distribution ratio for glutamine
 .during control preischaemic conditions, suggests an
uptake requiring energy. The metabolic energy needed
to influx glutamine is 7.72 kJ moly1. The available
Naq electrochemical energy at approximately 14.5 kJ
moly1 is more than sufficient for maintaining the
glutamine gradient, assuming a stoichiometry of 1:1
for glutamine and Naq. Like taurine, the settings of
the transporter can be reversed to efflux glutamine,
by the absence of the extracellular amino acid, mem-
w qxbrane depolarisation and a rise in Na .i
Unlike crystalloid cardioplegia, 30 min arrest with
blood cardioplegia provokes a small but insignificant
fall in tissue ATP, taurine and glutamine. The small
fall in tissue taurine and glutamine was surprising,
because blood contains the amino acids. The small
fall in tissue ATP is likely to be due to the fact that
the heart is rendered hypoxic during cold ischaemic
arrest with blood. Myocardial uptake of
haemoglobin-bound oxygen is greatly reduced with
w xhypothermic blood cardioplegia 33 .
4.2. Reperfusion with normothermic blood
The fall in tissue taurine and glutamine during
ischaemic arrest with cold crystalloid cardioplegic
solution was sustained after 20 min of normothermic
 .reperfusion Fig. 1 . On the other hand, reperfusion
following cold blood cardioplegic solution resulted in
 .a marked fall in the amino acids Fig. 1 . The sus-
tained fall in amino acids in the crystalloid group or
the marked fall in the blood group is surprising, as
the amino acids are present in the blood. As ex-
 .plained earlier see Section 4.1 , the changes in the
intracellular concentrations of taurine and glutamine
are related to transport and metabolism. It is known
that early after reperfusion, heart cells are further
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q loaded with Na resulting from a further fall in
.ATP but most importantly they are loaded with
Ca2q in exchange for Naq, a process associated with
cellular damage e.g., increased energy consumption
 w x.and reduced energy production see Ref. 30 . That
an increase in intracellular Naq has occurred is indi-
cated by the fall in ATP and the rise in lactate Table
.3 . The fall in taurine is another marker of a rise in
w qxNa , as the changes in taurine are largely due toi
 .transport see above . On the other hand the sustained
 .fall or marked fall in the blood group in glutamine
on reperfusion may have resulted from both Naq-de-
pendent efflux and its utilisation for energy produc-
tion.
A surprising observation obtained in this study is
the finding that even though blood cardioplegic solu-
tion maintained the levels of ATP and amino acids,
on reperfusion there was a marked fall in these
 .substrates Fig. 1 and Table 3 . This is in contrast to
the changes seen on reperfusion following arrest with
crystalloid cardioplegic solution. A likely explanation
for this effect is that blood cardioplegic solution
contains a much reduced concentration of magnesium
when compared to crystalloid cardioplegic solution
 .see Section 2 . The availability of magnesium during
the onset of reperfusion is likely to inhibit the NarCa
 w x. 2qexchanger see 27 and therefore reduce Ca over-
load. This in turn will help preserve ATP as seen in
the crystalloid group but not in the blood group. It
can also be argued that blood cardioplegic solution
contains oxygen which is a source of free radicals.
Availability of oxygen may provide a substrate for
generating free radicals at an early stage of reperfu-
sion when using blood cardioplegic solution. Free
radical-induced damage will result in Ca2q overload
and increased utilisation of ATP.
Although postischaemic metabolic derangement
has been documented in animal models, little data is
available showing this in humans during cardiac
 w x.surgery see 32 . In this work we provide evidence
showing that early after reperfusion, there is metabolic
derangement as seen by a sustained fall in the intra-
cellular concentrations of ATP and the amino acids.
The similar substrate derangement seen after is-
chaemia and reperfusion using crystalloid or blood
cardioplegic solution was associated with similar
myocardial injury as measured by the postoperative
 .release of troponins T and I Fig. 3 .
4.3. Clinical implications
This work suggests that heart cells utilise intra-
cellular taurine and glutamine to oppose a rise in
w qx Na provoked by ischaemiarreperfusion seei
. w qxabove . This is important because a rise in Na cani
2q w xlead to Ca overload and cellular damage 28,30 .
However, the loss of taurine and glutamine is likely
to affect recovery following cardiac surgery. Taurine
has several important roles which include membrane
2q w qxstabilisation, Ca mobilisation, Na regulation,i
regulation of phosphorylation of channels and trans-
 .porters see Section 1 . It is also implicated in the
maintenance of normal cardiac cellular function, as
illustrated by the fact that its depletion is associated
with the development of cardiomyopathy and that its
presence affects the consequences of ischaemia, hy-
poxia and the calcium paradox. As for the fall in
glutamine, the effects are many since glutamine is a
nitrogen donor for the biosynthesis of a number of
important compounds such as nucleotides and amino
acids and muscular glutamine has been shown to
increase protein synthesis, decrease protein degrada-
w xtion and regulate glycogen metabolism 14 .
4.4. General conclusion
Following ischaemia and reperfusion during coro-
nary artery bypass surgery, there is a fall in the
intracellular concentrations of taurine, glutamine and
ATP irrespective of the cardioplegic solution used to
arrest the heart. The fall in amino acids is closely
associated with metabolic stress as seen by a fall in
ATP and a rise in lactate; conditions known to induce
w qxa rise in Na . This in turn is likely to activate ai
Naq-dependent efflux of both taurine and glutamine.
In addition, glutamine can be utilised for energy
production. As these are important amino acids,
strategies to replenish them must be formulated which
must take into account better understanding of their
transport.
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